During the past decade, South East Dermatology Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "South East Dermatology Centre" #1 collaborator was "TKL Research, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "South East Dermatology Centre" are "Actinic Keratosis" (3 trials) and "Superficial Basal Cell Carcinoma" (1 trials). Many other conditions were trialed in "South East Dermatology Centre" in a lesser frequency.

Most popular intervention types in "South East Dermatology Centre" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Imiquimod 5% cream" (1 trials), "Ingenol mebutate gel 0.05%" (1 trials), "Lesion count" (1 trials), "PEP005 (Ingenol Mebutate) gel, 0.015%" (1 trials) and "Vehicle Gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "South East Dermatology Centre" are 4 trials for "All" genders.

Currently, there are NaN active trials in "South East Dermatology Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in South East Dermatology Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in South East Dermatology Centre, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".